Lumbar-sacral bone marrow dose modeling for acute hematological toxicity in anal cancer patients treated with concurrent chemo-radiation.
about
Hematologic toxicity in anal cancer patients during combined chemo-radiation: a radiation oncologist perspective.Image-guided IMRT with simultaneous integrated boost as per RTOG 0529 for the treatment of anal cancer.Incorporating 18FDG-PET-defined pelvic active bone marrow in the automatic treatment planning process of anal cancer patients undergoing chemo-radiation.
P2860
Lumbar-sacral bone marrow dose modeling for acute hematological toxicity in anal cancer patients treated with concurrent chemo-radiation.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Lumbar-sacral bone marrow dose ...... th concurrent chemo-radiation.
@en
Lumbar-sacral bone marrow dose ...... th concurrent chemo-radiation.
@nl
type
label
Lumbar-sacral bone marrow dose ...... th concurrent chemo-radiation.
@en
Lumbar-sacral bone marrow dose ...... th concurrent chemo-radiation.
@nl
prefLabel
Lumbar-sacral bone marrow dose ...... th concurrent chemo-radiation.
@en
Lumbar-sacral bone marrow dose ...... th concurrent chemo-radiation.
@nl
P2093
P2860
P1433
P1476
Lumbar-sacral bone marrow dose ...... th concurrent chemo-radiation.
@en
P2093
Francesca Arcadipane
Mario Morino
Massimiliano Mistrangelo
Nadia Rondi
Paola Cassoni
Patrizia Racca
Riccardo Ragona
Umberto Ricardi
P2860
P2888
P356
10.1007/S12032-016-0852-7
P577
2016-11-04T00:00:00Z